Ventilato Market to reach USD 1.92 Bn by 2029, emerging at a CAGR of 8.2 percent and …
… breathe. In hospitals, it is mostly used to treat chronic obstructive pulmonary disease (COPD), sleep apnea, acute lung damage, and hypoxemia.
… breathe. In hospitals, it is mostly used to treat chronic obstructive pulmonary disease (COPD), sleep apnea, acute lung damage, and hypoxemia.
